When a new type of immunotherapy called CAR T-cell therapy was approved by the US Food and Drug Administration in 2017, it gave patients who had exhausted other treatment options hope where there was ...

An innovative type of CAR T cell therapy, called KIR-CAR, was shown to be safe, with increasing efficacy corresponding to higher doses of the investigational treatment in nine patients with advanced ...

Chimeric antigen receptor T-cell therapy—CAR T for short—has been a major advance in treating blood cancers like leukemia and lymphoma. But the immunotherapy has struggled against solid tumors for two ...

CAR T-cell therapy, which transforms patients’ own immune cells into cancer-fighting warriors, has revolutionized how physicians treat cancer, especially blood cancers. “These patients can be cured ...

Wistar scientists have developed a new type of bispecific T cell engager, or BTE, that is effective against ovarian cancer in ...

Researchers used CRISPR to remove the CD33 protein from donor stem cells, protecting healthy blood cells from therapies that ...

Sam Neill fought stage 3 angioimmunoblastic T-cell lymphoma, a rare type of blood cancer, but found success in treatment with a clinical trial.

A large international study found that patients treated with CAR T-cell therapy had 18 healthy babies, suggesting many may still be able to conceive naturally after treatment.